Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ADMA BIOLOGICS, INC. | Director | Stock Option (right to buy) | 37.5K | $137K | $3.66 | Feb 26, 2024 | Direct |
ADMA BIOLOGICS, INC. | Director | Common Stock | 24K | $126K | $5.26 | Feb 26, 2024 | Direct |
Decibel Therapeutics, Inc. | Director | Common Stock | 0 | $5.03 | Sep 25, 2023 | Direct | |
Decibel Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Sep 25, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADMA | ADMA BIOLOGICS, INC. | Feb 26, 2024 | 2 | $0 | 4 | Feb 28, 2024 | Director |
ADMA | ADMA BIOLOGICS, INC. | Sep 28, 2023 | 0 | $0 | 3 | Oct 2, 2023 | Director |
DBTX | Decibel Therapeutics, Inc. | Sep 25, 2023 | 4 | $0 | 4 | Sep 25, 2023 | Director |
DBTX | Decibel Therapeutics, Inc. | Jun 13, 2023 | 2 | $0 | 4 | Jun 14, 2023 | Director |
DBTX | Decibel Therapeutics, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
DBTX | Decibel Therapeutics, Inc. | Dec 3, 2021 | 1 | $0 | 4 | Dec 6, 2021 | Director |
DBTX | Decibel Therapeutics, Inc. | Dec 3, 2021 | 0 | $0 | 3 | Dec 6, 2021 | Director |